Replies to post #22315 on Amarin Corp Plc (AMRN)

[zumantu]

Eventually the price will reflect value

Amarin will increase Rx if not with anchor label (remote possibility. ) then with partnership and using Anchor results similar to how Combos is on Lovaza label . So in two years they should get scripts into a run rate approaching $300M / year so that's $1B mkt cap, maybe more since they have Patents for 17 Years, add $200-$400M for the raffle ticket called Reduce It that at even odds of 50/50 with a payout of $5B for 10 years... I 'd love a raffle ticket that has 50% odds of winning and a payout of $50 Billion over 10 years .... :-)

So in 24 months, $1.4B - assuming they are not bought before then

I don't add any value for Anchor, but what if we see a compromised label in 2014 ? in which case your $5 is low

The reason is still under $2 now is the final shoe to drop (CRL) is expected by 12/20 and why shorts feel justified.

Let's check this post after 12/20

[Biobillionair]

>$30